●1976

In June, the company was planned to be established in Jingzhong Commune, Linzi District, named Zibo Linzi Pharmaceutical Factory, which was a socially run factory.

●1977

In February, the Health Bureau, Commerce Bureau, and Chemical Petroleum Industry Bureau of the Shandong Provincial Revolutionary Committee issued the "About Approval of Linzi Pharmaceutical" with (77) Luwei Pharmaceutical No. 9 Approval The factory was included in the production plan, and the company's production was officially included in the Shandong Province plan.

In March, Hu Bingshuang served as party branch secretary.

In April, the 500ml large infusion (sodium chloride injection) workshop was successfully put into production.

●1978

In January, the small injection (hydrocortisone) workshop was successfully put into production.

In March, ammonium chloride API was successfully put into production.

In August, Zhang Xianggui served as factory director.

In November, the Linzi District Revolutionary Committee issued the "Reply on the Transformation of Linzi Pharmaceutical Factory into a District-Community Joint Office" with Approval No. (78) 98. The nature of the enterprise was changed from a social-run office to a district-community-run joint office. According to District collective enterprise management.

In December, the small-injection drug Antoxin was successfully put into production.

●1979

In October, in the provincial infusion industry quality evaluation organized by Shandong Pharmaceutical Corporation, Linzi Pharmaceutical Factory won the first place in the overall score and has been ranked first for five consecutive years. Won this honor in year.

In October, Jiang Danfu served as factory director.

●1982

In March, the syrup workshop was successfully put into operation.

●1983

In April, the tincture workshop was successfully put into operation. There are mercurochrome solution, methylene violet solution and iodine tincture.

In May, the 250ml infusion workshop was successfully put into production, filling a gap in the province.

●1984

In October, 500ml Glucose Sodium Chloride Injection was rated as a high-quality product in Shandong Province.

●1985

In March, Jiang Danfu and Zhang Bingzhi served as party branch secretary and factory director respectively.

In May, groundwater was contaminated and the company was forced to suspend production.

In December, when the water quality from the wells was still unqualified, the company began to pull water from a long distance to start self-production, which lasted for three years.

In December, the factory Youth League branch was rated as the provincial advanced Youth League branch.

●1986

In March, the Municipal Construction Committee issued the "Approval on the Designated Construction of Linzi Pharmaceutical Factory in Xindian" with Approval No. (86) 40, approving the company's relocation to Xindian. The factory area is 72.46 acres.

In May, the carton workshop was successfully put into production.

In September, the company started construction of the first phase of the new factory in Xindian.

●In September 1987, the company implemented the factory director responsibility system and the factory director's term target responsibility system.

●1988

In February, the first phase of the new factory was completed, and the enterprise management organization and the first and fourth workshops were moved to the new location.

In March, Wang Huaiyuan, deputy secretary of the Zibo Municipal Party Committee and mayor, came to inspect the factory.

In May, workshops one and four were put into production.

In June, the company name was changed to Shandong Linzi Pharmaceutical Factory, and the original Jingzhong factory was named Linzi Pharmaceutical Factory No. 1 Branch.

In December, the dispute over groundwater pollution that lasted for more than three years with Qilu Petrochemical came to fruition, and it was awarded a compensation of 1 million yuan.

In December, the Shandong Provincial Department of Labor approved the conversion of 260 key production and management personnel in our factory into farmer contract workers.

●1990

In March, the company was awarded the titles of municipal advanced enterprise and municipal civilized factory by the municipal government.

In April, Wang Xiaozhou became the factory director.

In April, Qi Moujia, director of the State Administration of Medicine, came to inspect the factory.

In October, Metronidazole G Injection was rated as a high-quality product in Shandong Province.

In October, the powdered sugar workshop was put into operation.

In November, the enterprise was upgraded from a district collective small (I) enterprise to a medium-sized (II) enterprise with the approval of the municipal government.

●In August 1991, Li Jinsong served as factory director and party branch secretary.

In December, the enterprise was lifted from the status of jointly run by the district and community and was completely placed under the jurisdiction of the district.

In December, the annual infusion output exceeded 10 million bottles for the first time.

●1992

In November 1992, the enterprise was upgraded from a medium-sized (II) enterprise to a medium-sized (I) enterprise with the approval of the Provincial Economic Commission and the Provincial Bureau of Statistics.

●1993

In March, Li Zhentao served as factory director and party branch secretary.

In April, the company was rated as one of the 500 largest pharmaceutical industry enterprises in China by the National Bureau of Statistics.

In December, the company implemented a joint-stock pilot program and established Shandong Linzi Pharmaceutical Co., Ltd., but later withdrew from the pilot program.

●In September 1994, the company implemented the asset management responsibility system.

●1995

In March, the company established a general party branch, and Li Zhentao concurrently served as secretary of the general party branch.

●1996

In September, the new product Lanqin Oral Liquid jointly developed with Shandong Medical University obtained the new drug certificate and production approval. This product fills the domestic gap. Later transferred externally.

●1997

In April, Zheng Jiaqing and Zhang Fuquan served as factory director and party branch secretary respectively.

In November, the company shut down its powdered sugar workshop that had been losing money for many years.

●1998

In June, Zheng Jiaqing concurrently served as secretary of the party branch.

In June, the company held a joint-stock cooperative establishment meeting to implement the reform of the property rights system. Zheng Jiaqing serves as chairman and general manager, and Cui Pingan and others serve as directors.

In August, the first and second workshops passed the Shandong Province GMP compliance inspection and acceptance.

In December, the company was restructured and turned around, ending its long-term loss situation.

●1999

In March, Zhang Sizhong, vice president of China Chemical and Pharmaceutical Industry Association, and Shen Xianji, secretary-general, came to the factory for investigation.

In December, funds were raised to build a 5,000-square-meter living building, which alleviated the housing problem for employees.

●2000

In March, the new cerebrovascular drug Bufumai (Buflodil Hydrochloride and Sodium Chloride Injection) obtained the new drug certificate and production approval. Later, a sustained-release tablet form was added. This product fills the domestic gap and is rated as a national key new product and a Shandong Province trademark product.

In May, Shandong Dongbo New Drug Research and Development Center was jointly established with Shandong Medical University.

In December, workshops one and two obtained national GMP certification.

In December, the total annual profit and tax exceeded 10 million yuan for the first time.

●2001

In January, the new broad-spectrum antibacterial drug Dinoxin (levofloxacin hydrochloride and sodium chloride injection) obtained the new drug certificate and production approval. Later, tablet dosage forms were added.

In June, Li Min, director of the Shandong Provincial Food and Drug Administration, accompanied by Wang Mouchang, director of the Zibo City Food and Drug Administration, came to inspect the factory.

In December, the additional infusion production workshop (the third workshop) with an annual output of 30 million bottles was successfully put into operation and successfully passed the national GMP certification.

●2002

In February, the company established a party committee, with Zheng Jiaqing as party committee secretary and Zhang Zhaoli as deputy secretary.

In February, Yan Qijun, Secretary of the Zibo Municipal Party Committee, came to inspect the company.

In August, the registered trademark Qidu brand won the title of Famous Trademark of Shandong Province.

●2003

In January, the comprehensive preparation workshop (tablets, granules, powders, syrups) completed technical transformation and successfully passed the national GMP certification.

In July, the company was rated as a high-tech enterprise in Shandong Province by the Shandong Provincial Department of Science and Technology.

In December, the company was rated as a provincial-level contract-abiding and credit-worthy enterprise by the Shandong Provincial Administration for Industry and Commerce.

In December, the annual infusion output exceeded 100 million bottles for the first time.

●2004

In April, Shandong Donglin Drug Research and Development Center was jointly established with Shandong University of Traditional Chinese Medicine.

In May, the enterprise drug research center was recognized as a provincial enterprise technology center by the Provincial Economic and Trade Commission.

In May, the corporate structure was regulated as a limited liability company and the company name was changed to Shandong Qidu Pharmaceutical Co., Ltd. Zheng Jiaqing serves as chairman and general manager.

In May, Zibo Jingrui Packaging Co., Ltd., the company’s first holding subsidiary, was officially established.

In May, Liu Huiyan, deputy secretary of the Zibo Municipal Party Committee and mayor, came to the company for inspection.

In May, the company was rated as a key high-tech enterprise in the National Torch Plan by the Ministry of Science and Technology.

In May, Zheng Jiaqing was elected as director of the Provincial Pharmaceutical Association.

In June, the API (ammonium chloride) workshop completed technical transformation and successfully passed the national GMP certification.

In June, the company’s Party Committee was rated as the Advanced Grassroots Party Committee of Zibo City by the Zibo Municipal Party Committee and the Municipal Government.

In September, the company was elected as a governing unit of the China Chemical and Pharmaceutical Industry Association, and Zheng Jiaqing was elected as a director.

●2005

In January, the company built a new production workshop for non-PVC flexible packaging infusions with an annual output of 15 million bags (workshop seven), and a new production workshop for glass bottle infusions with an annual output of 120 million bottles ( The fourth workshop) and the modified comprehensive preparation workshop (capsules, anti-tumor infusion) have passed the national GMP certification.

In January, the first workshop was awarded the honorary title of provincial science popularization workshop by the Provincial Association for Science and Technology.

In May, Zheng Jiaqing was named one of the top ten outstanding young people in Zibo City.

In July, the company was rated as a key enterprise in the national biopharmaceutical industry base by the Ministry of Science and Technology.

In September, the new chemotherapy antiemetic drug Tropisetron Hydrochloride API and injection obtained the new drug certificate and production approval. This product fills the domestic gap.

In September, the construction of Qidu Pharmaceutical Science and Technology Park started, and urban leaders Yue Changzhi, Duan Liwu, Xie Weijun and others attended the groundbreaking ceremony.

In November, Zhang Jianguo, Secretary of the Zibo Municipal Party Committee and Director of the Standing Committee of the Municipal People’s Congress, came to inspect the construction site of Qidu Pharmaceutical Science and Technology Park.

In December, Lou Hongxiang, Vice President of Shandong University and Dean of the School of Pharmacy, came to the company for investigation.

In December, the company was named the Provincial Youth Civilization Number by the Shandong Provincial Committee of the Communist Youth League.

In December, the company fully completed the butyl rubber stopper experimental tasks assigned by the China Chemical and Pharmaceutical Industry Association and fully completed the butyl rubber stopper switch as planned.

In December, the annual infusion output exceeded 200 million bottles (bags) for the first time, ranking first in Shandong Province and fifth in the country in the infusion industry.

●2006

In February, the raw materials (lipoic acid, telmisartan, tropisetron hydrochloride) successfully passed the national GMP certification.

In February, the company held a budget management work meeting, marking the initial inclusion of corporate management into the track of budget management.

In March, the new liver disease drug metadoxin API and tablets obtained the new drug certificate and production approval. This product fills the domestic gap.

In April, the company officially launched the ERP application system.

In May, the pilot production of biopharmaceutical adenosylmethionine was successful.

In May, the first workshop of Qidu Pharmaceutical Technology Park was completed and put into production.

In June, the company held a celebration event for the 30th anniversary of the founding of the factory.

In June, Feng Bo, the company’s deputy general manager, won the title of “Zibo Outstanding Young Intellectuals” and was honored with third-class merit.

In August, the company obtained production approval documents for the specifications of compound amino acids, fat emulsion injection and fluconazole capsules.

In August, the company’s metadoxin API passed GMP certification.

In September, the company’s 101 workshop passed GMP certification. It marks that the development of Qidu Pharmaceutical has entered a new historical period.

In September, the company’s 103 workshop passed GMP re-certification.

In October, the company was rated as a Consumer Satisfaction Unit in Shandong Province by the Sixth Consumers Association of Shandong Province.

In October, the company was recognized by the National Bureau of Statistics as one of the top ten innovative enterprises in the national chemical pharmaceutical preparation manufacturing industry.

In November, the pilot test of adenosylmethionine, a biotechnology product developed by the company, was successful.

In December, the company’s R&D center was recognized as the Shandong Provincial Plasma Substitute Engineering Technology Research Center by the Shandong Provincial Department of Science and Technology.

●2007

In January, the company's "propionyl-L-carnitine synthesis process" won the national invention patent.

In February, Zhang Zhaoli, deputy secretary of the Party Committee, won the title of "Revitalizing Zibo Labor Medal".

In March, the company’s fourth general meeting of shareholders was successfully held, forming a new board of directors and board of supervisors. Zheng Jiaqing serves as chairman.

In April, the company's "Metadoxine Tablets and Preparation Method" were awarded an invention patent certificate by the State Intellectual Property Office.

In April, Chairman Zheng Jiaqing was awarded the title of “Zibo Model Worker”.

In April, the company was rated as one of the "Top 100 Outstanding Industrial Enterprises in Zibo City" by the Zibo Municipal Party Committee and the Municipal Government, and Chairman Zheng Jiaqing was awarded the title of "Top 100 Outstanding Industrial Entrepreneurs in Zibo City".

In June, the company was rated as a "Demonstration Site for Grassroots Party Building Work in Shandong Province" by the Organization Department of the Shandong Provincial Party Committee.

In July, the construction of Workshop 201 in the Science and Technology Park was successfully completed and put into trial production.

In August, the company was recognized as "China Patent Shandong Star Enterprise" by the Shandong Provincial Science and Technology Bureau and the Shandong Provincial Intellectual Property Office.

In September, the company was rated as a "National Contract-abiding and Credit-worthy Enterprise" by the State Administration for Industry and Commerce.

In October, the company’s 601 workshop started construction.

In October, the company's products "Aminobutyric Sodium Chloride Injection" and "Metadoxine Tablets" successfully passed the GMP certification.

In October, the construction of staff apartments, staff restaurants and multi-functional halls in the company's science and technology park began.

In December, the company’s chairman Zheng Jiaqing was elected as a representative of the Zibo Municipal People’s Congress.

In December, Liu Yanhua, Vice Minister of the Ministry of Science and Technology, came to the company to inspect the work.

In December, the company's product "Ganxin" was rated as a national key new product by the Ministry of Science and Technology.

●2008

In February, the company’s 405 and 406 workshops passed GMP re-certification.

In February, the company was rated as "Top 100 Outstanding Industrial Enterprises in Zibo City" and "Top 50 Taxpaying Enterprises in Zibo City" by the Municipal Party Committee and Municipal Government.

In March, the company’s 201 workshop successfully passed the GMP certification.

In April, the company was elected as a governing unit of the China Chemical and Pharmaceutical Association, and Chairman Zheng Jiaqing was re-elected as a director.

In April, the company’s employee relief fund was established.

In May, Deputy General Manager Feng Bo won the title of “Top Ten Outstanding Young People in Linzi District”.

In June, the company successfully passed the national AAA measurement certification.

In June, the company was elected as the deputy director unit of the Infusion Professional Committee of the China Chemical and Pharmaceutical Industry Association.

In July, the company passed the national standardization good behavior AAA enterprise certification, ISO9001 international quality management system certification and ISO14001 international environmental management system certification.

In August, Chairman Zheng Jiaqing won the title of "Top Ten Most Responsible Enterprises in Zibo City".

In October, the staff apartment, staff restaurant and multi-functional hall of the company's science and technology park were put into use.

In October, the "Synthesis Technology of Propionyl-L-Carnitine Internal Salt" in the "Research and Development of Propionyl-Carnitine Chloride Raw Materials and Preparations" jointly developed by the company and Shandong University was The State Intellectual Property Office grants invention patents.

In November, Workshop 301 passed GMP certification.

In December, the company's "Qidu brand" and "Bufumai" trademarks were rated as famous trademarks in Shandong Province.

In December, the company was awarded the first batch of graduate employment demonstration bases in Zibo City by the Zibo City Personnel Bureau.

In December, the company's product "Metadoxin Tablets" project was listed as a National Torch Plan project by the Ministry of Science and Technology.

●2009

In January, the registration application for the aluminum-plastic combination cap for infusion bottles produced by Jingrui Packaging passed the municipal and provincial production site assessment.

In March, the company was rated as an advanced intellectual property collective in Zibo by the Zibo Science and Technology Bureau.

In March, the product Metadoxin Tablets was awarded the first prize of Science and Technology Progress Award by Zibo Science and Technology Bureau.

In April, the company was rated as one of the city's top 100 outstanding industrial enterprises by the Zibo Municipal Party Committee and Government, and the company's chairman Zheng Jiaqing was rated as an outstanding entrepreneur.

In May, the company was rated as "Advanced Group for Monitoring Adverse Drug Reactions in the City" by Zibo Food and Drug Administration.

In May, the company's research and development products "Nuan Gong Zhengzi Capsules", "Tongqiao Rhinitis Tablets" and "Nicergoline for Injection" successively obtained drug approval numbers.

In September, the "Qidu" brand trademark was judged as a "China's Well-known Trademark" by the Zibo Municipal Court.

In November, workshops 202, 302, and 102 successfully passed the national GMP certification; workshops 104 and 307 successfully passed the national GMP certification review.